{"type":"knowledge-graph","data":{"nodes":[{"id":"node-1","label":"CRISPR Gene Editing","type":"SOURCE","confidence":0.98,"metadata":{"sources":["Nature Biotech","MIT Review"],"description":"Precise DNA modification technology.","category":"Science"}},{"id":"node-2","label":"Gene Therapy","type":"CONCEPT","confidence":0.94,"metadata":{"sources":["Clinical Trials"],"description":"Treating diseases by altering genes.","category":"Medicine"}},{"id":"node-3","label":"Personalized Medicine","type":"CONCEPT","confidence":0.9,"metadata":{"sources":["Genomics Study"],"description":"Tailoring treatment to individual genetic profiles.","category":"Health"}},{"id":"node-4","label":"FDA Regulatory Sandbox","type":"REGULATION","confidence":0.87,"metadata":{"sources":["FDA Guidelines"],"description":"Experimental regulatory frameworks for biotech.","category":"Legal"}},{"id":"node-5","label":"Longevity Industry","type":"OPPORTUNITY","confidence":0.82,"metadata":{"sources":["Wealth Report"],"description":"Market focused on extending human lifespan.","category":"Economic"}}],"edges":[{"id":"edge-1","source":"node-1","target":"node-2","relation":"powers","weight":0.95,"evidence":["CRISPR is the core engine for modern gene therapy."]},{"id":"edge-2","source":"node-2","target":"node-3","relation":"leads-to","weight":0.9,"evidence":["Specific genetic cures enable personalized health."]},{"id":"edge-3","source":"node-3","target":"node-4","relation":"triggers","weight":0.85,"evidence":["New drug classes require updated approval processes."]},{"id":"edge-4","source":"node-4","target":"node-5","relation":"accelerates","weight":0.8,"evidence":["Legal clarity invites investment in longevity."]}]}}